tirzepatide approved for obesity F.D.A. Approves New Drug That Will Compete With Wegovy In adults with obesity but

Clinical trials and prospective studies will be essential

The rate of weight reduction during obesity treatment declines over time and eventually reaches a weight plateau

Get affordable injectable semaglutide.

semaglutide for weight loss in 2026

Among patients with polycystic ovary syndrome (PCOS), the median one-year weight change was an 11.5% loss for those treated with a GLP-1, compared to a 1.9% loss among those treated with metformin.

This systematic review evaluates the literature on the relationship between GLP-1 RA use and increased regurgitation and aspiration events to contextualize the existing, consensus-based guidelines put forth by the ASA in light of limited comparative evidence